Establishment Labs Q3 net loss narrows to $10.71 million; Q3 revenue rises 34% to $71.99 million

By Public Technologies
  • Establishment Labs’ third-quarter 2026 net loss narrowed to $10.71 million.
  • Revenue climbed 34% to $72 million, while U.S. revenue more than doubled to $26 million.
  • Operating cash flow turned positive at $7.7 million, marking its first positive quarter.
  • The U.S. commercial footprint expanded to more than 2,100 accounts, with more than 400 plastic surgeons trained on Preservé.
  • Full-year 2026 revenue guidance rose to more than $274 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610290800BIZWIRE_USPR_____20261029_BW198419) on October 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.